# Olema Pharmaceuticals, Inc.: Form 8-K, filed Dec 2, 2024

- Company: [Olema Pharmaceuticals, Inc.](/companies/olma.md) (CIK 1750284)
- Form: 8-K
- Filed: 2024-12-02
- Accepted by EDGAR: Dec 2, 2024, 12:15 ET
- Period: 2024-11-29
- Accession: 0000950170-24-131965
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1750284/000095017024131965/olma-20241129.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1750284/000095017024131965/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1750284/000095017024131965/olma-20241129.htm

Filed Dec 2, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-131965. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.